Bausch Health Companies (BHC) Cost of Revenue (2009 - 2026)

Bausch Health Companies has disclosed Cost of Revenue across 18 years of filings, most recently posting $47.0 million for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $47.0 million, down 53.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $554.0 million (up 69.94% YoY), and the FY2024 annual result was $449.0 million, up 475.64% from the prior year.
• Cost of Revenue came in at $47.0 million for Q1 2026 at Bausch Health Companies, up from -$4.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $612.0 million in Q3 2023 to a low of -$1.7 billion in Q4 2022.
• The 5-year median for Cost of Revenue is $102.0 million (2025), against an average of $104.7 million.
• Across the five-year window, Cost of Revenue tumbled 9372.22% in 2022 and soared 350.44% in 2025, its largest moves.
• Bausch Health Companies' Cost of Revenue stood at -$1.7 billion in 2022, then jumped by 102.88% to $48.0 million in 2023, then jumped by 131.25% to $111.0 million in 2024, then slumped by 103.6% to -$4.0 million in 2025, then surged by 1275.0% to $47.0 million in 2026.
• The last three Cost of Revenue figures came in at $47.0 million (Q1 2026), -$4.0 million (Q4 2025), and $509.0 million (Q3 2025), per Business Quant data.